Detalhe da pesquisa
1.
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Trials
; 23(1): 263, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382844
2.
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.
J Infect Dis
; 201(5): 720-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20132004
3.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617268
4.
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One
; 9(3): e90378, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24609066
5.
A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4ß7-binding V2 loop of HIV gp120 in healthy volunteers.
Clin Vaccine Immunol
; 19(9): 1557-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22837097
6.
Scleredema of Buschke.
Eur J Rheumatol
; 3(4): 191-192, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28149667
7.
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.
J Immunol Methods
; 370(1-2): 43-54, 2011 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21669205
8.
Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
J Med Virol
; 70(3): 337-42, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12766994